Welcome
We offer a diverse set of research and academic experiences that reflect the interdisciplinary nature of neuroscience. Over one hundred faculty from two campuses combine coursework and experiential learning in basic, clinical and translational science, providing an exceptionally broadly based education.
We also foster an atmosphere of collaboration between investigators, theorists, and experimentalists, where students learn the value of a problem-oriented approach to research. Guidance and mentorship are an integral part of the Columbia experience.
We invite you to learn more about the Columbia University Doctoral Program in Neurobiology and Behavior.
The Doctoral Program in Neurobiology and Behavior trains its students in the exploration of the nervous system at the level of molecules, cells, development, circuits and systems, theory, and behavior.
Each entering student in the doctoral program interacts closely with program co-directors and program faculty during orientation, first semester courses, personal meetings, and a series of lab rotations.
The mentors at Columbia that participate in the Neurobiology and Behavior training program are both exceptionally accomplished and highly collegial. Learn more about faculty research interests by exploring these pages.
The breadth of opportunity in our program is enhanced by the fact that faculty mentors in the program have appointments across several different university departments.
News
Columbia NB&B Alum Grace Lindsay Releases a New Book
For more information about Grace and "Models of the Mind: How Physics, Engineering and Mathematics Have Shaped Our Understanding of the Brain," click here.
IMPORTANT: C.A.N. APPLICATON DEADLINE EXTENDED TO MARCH 4th
NB&B Alum Briana Chen Named One of Forbes 30 Under 30 in Healthcare
"Briana Chen is a researcher at Columbia University whose research focuses on gender disparities in the mental health field. Her work has uncovered that women are twice as likely as men to develop depression, but often have some different symptoms. As a result, she is in the process of creating the first female-specific antidepressants."
See full page here